Global Synthetic Biology Platforms
Global Synthetic Biology Platforms

Synthetic Biology Platforms Comprehensive Study by Type (Synthetic Biological Tool (Oligonucleotides, Enzymes, Synthetic Cells), Synthetic Biotechnology), Application (Gene Synthesis, Genome Engineering, Cloning, Sequencing, Site-directed Mutagenesis, Measurement and Modeling, Microfluidics, Nanotechnology, Bioinformatics), End User (Medical, Industry, Agriculture, Environmental) Players and Region - Global Market Outlook to 2025

Synthetic Biology Platforms Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Aug 2020 Edition 224 Pages 211 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Synthetic Biology Platforms Market Overview:
The global Synthetic Biology Platform market is expected to witness high demand in the forecasted period due to increasing research in synthetic drugs and vaccines in the forecasted period. Synthetic Biology offers innovative approaches for engineering new biological systems or redesigning existing ones for useful purposes. The growing demand from Gene Synthesis, Genome Engineering, Cloning will help to boost the global Synthetic Biology Platform market in the forecasted period.

Growth Drivers
  • Upsurging Demand due to Wide Range of Applications of Synthetic Biology
  • Growing Investments in the Market

Market Trends
  • Rising R&D Funding and Growing Initiatives in Synthetic Biology
  • Declining Cost of DNA Sequencing and Synthesizing

Roadblocks
  • The Growing Concern Related to Biosafety, Biosecurity, and Ethical

Opportunities
  • Upsurging Requirement of Fuel Alternatives
  • High Adoption due to Protein Therapeutics and Personalized Medicine

Challenges
  • Standardization of Biological Parts


Competitive Landscape:
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are Novozymes (Denmark), Merck (United States), Intrexon (United States), Amyris (United States), GenScrip (United States), Integrated DNA Technologies (United States), Synthetic Genomics (United States), DSM (Netherlands) and Locus Biosciences (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Synthetic Biology Platforms market by 2025. Considering Market by End User, the sub-segment i.e. Medical will boost the Synthetic Biology Platforms market.

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Synthetic Biology Platforms market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Synthetic Biology Platforms market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Synthetic Biology Platforms Providers, Government Regulatory Bodies, Private Research Organization, Government Research Organization and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.
Report Objectives / Segmentation Covered
By Type
  • Synthetic Biological Tool [Oligonucleotides, Enzymes, Synthetic Cells]
  • Synthetic Biotechnology
By Application
  • Gene Synthesis
  • Genome Engineering
  • Cloning
  • Sequencing
  • Site-directed Mutagenesis
  • Measurement and Modeling
  • Microfluidics
  • Nanotechnology
  • Bioinformatics
By End User
  • Medical
  • Industry
  • Agriculture
  • Environmental

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Upsurging Demand due to Wide Range of Applications of Synthetic Biology
      • 3.2.2. Growing Investments in the Market
    • 3.3. Market Challenges
      • 3.3.1. Standardization of Biological Parts
    • 3.4. Market Trends
      • 3.4.1. Rising R&D Funding and Growing Initiatives in Synthetic Biology
      • 3.4.2. Declining Cost of DNA Sequencing and Synthesizing
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Synthetic Biology Platforms, by Type, Application, End User and Region (value and price ) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Synthetic Biology Platforms (Value)
      • 5.2.1. Global Synthetic Biology Platforms by: Type (Value)
        • 5.2.1.1. Synthetic Biological Tool [Oligonucleotides, Enzymes, Synthetic Cells]
        • 5.2.1.2. Synthetic Biotechnology
      • 5.2.2. Global Synthetic Biology Platforms by: Application (Value)
        • 5.2.2.1. Gene Synthesis
        • 5.2.2.2. Genome Engineering
        • 5.2.2.3. Cloning
        • 5.2.2.4. Sequencing
        • 5.2.2.5. Site-directed Mutagenesis
        • 5.2.2.6. Measurement and Modeling
        • 5.2.2.7. Microfluidics
        • 5.2.2.8. Nanotechnology
        • 5.2.2.9. Bioinformatics
      • 5.2.3. Global Synthetic Biology Platforms by: End User (Value)
        • 5.2.3.1. Medical
        • 5.2.3.2. Industry
        • 5.2.3.3. Agriculture
        • 5.2.3.4. Environmental
      • 5.2.4. Global Synthetic Biology Platforms Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Synthetic Biology Platforms (Price)
      • 5.3.1. Global Synthetic Biology Platforms by: Type (Price)
  • 6. Synthetic Biology Platforms: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Novozymes (Denmark)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Merck (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Intrexon (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Amyris (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. GenScrip (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Integrated DNA Technologies (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Synthetic Genomics (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. DSM (Netherlands)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Locus Biosciences (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Synthetic Biology Platforms Sale, by Type, Application, End User and Region (value and price ) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Synthetic Biology Platforms (Value)
      • 7.2.1. Global Synthetic Biology Platforms by: Type (Value)
        • 7.2.1.1. Synthetic Biological Tool [Oligonucleotides, Enzymes, Synthetic Cells]
        • 7.2.1.2. Synthetic Biotechnology
      • 7.2.2. Global Synthetic Biology Platforms by: Application (Value)
        • 7.2.2.1. Gene Synthesis
        • 7.2.2.2. Genome Engineering
        • 7.2.2.3. Cloning
        • 7.2.2.4. Sequencing
        • 7.2.2.5. Site-directed Mutagenesis
        • 7.2.2.6. Measurement and Modeling
        • 7.2.2.7. Microfluidics
        • 7.2.2.8. Nanotechnology
        • 7.2.2.9. Bioinformatics
      • 7.2.3. Global Synthetic Biology Platforms by: End User (Value)
        • 7.2.3.1. Medical
        • 7.2.3.2. Industry
        • 7.2.3.3. Agriculture
        • 7.2.3.4. Environmental
      • 7.2.4. Global Synthetic Biology Platforms Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Synthetic Biology Platforms (Price)
      • 7.3.1. Global Synthetic Biology Platforms by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Synthetic Biology Platforms: by Type(USD Million)
  • Table 2. Synthetic Biology Platforms Synthetic Biological Tool [Oligonucleotides, Enzymes, Synthetic Cells] , by Region USD Million (2014-2019)
  • Table 3. Synthetic Biology Platforms Synthetic Biotechnology , by Region USD Million (2014-2019)
  • Table 4. Synthetic Biology Platforms: by Application(USD Million)
  • Table 5. Synthetic Biology Platforms Gene Synthesis , by Region USD Million (2014-2019)
  • Table 6. Synthetic Biology Platforms Genome Engineering , by Region USD Million (2014-2019)
  • Table 7. Synthetic Biology Platforms Cloning , by Region USD Million (2014-2019)
  • Table 8. Synthetic Biology Platforms Sequencing , by Region USD Million (2014-2019)
  • Table 9. Synthetic Biology Platforms Site-directed Mutagenesis , by Region USD Million (2014-2019)
  • Table 10. Synthetic Biology Platforms Measurement and Modeling , by Region USD Million (2014-2019)
  • Table 11. Synthetic Biology Platforms Microfluidics , by Region USD Million (2014-2019)
  • Table 12. Synthetic Biology Platforms Nanotechnology , by Region USD Million (2014-2019)
  • Table 13. Synthetic Biology Platforms Bioinformatics , by Region USD Million (2014-2019)
  • Table 14. Synthetic Biology Platforms: by End User(USD Million)
  • Table 15. Synthetic Biology Platforms Medical , by Region USD Million (2014-2019)
  • Table 16. Synthetic Biology Platforms Industry , by Region USD Million (2014-2019)
  • Table 17. Synthetic Biology Platforms Agriculture , by Region USD Million (2014-2019)
  • Table 18. Synthetic Biology Platforms Environmental , by Region USD Million (2014-2019)
  • Table 19. South America Synthetic Biology Platforms, by Country USD Million (2014-2019)
  • Table 20. South America Synthetic Biology Platforms, by Type USD Million (2014-2019)
  • Table 21. South America Synthetic Biology Platforms, by Application USD Million (2014-2019)
  • Table 22. South America Synthetic Biology Platforms, by End User USD Million (2014-2019)
  • Table 23. Brazil Synthetic Biology Platforms, by Type USD Million (2014-2019)
  • Table 24. Brazil Synthetic Biology Platforms, by Application USD Million (2014-2019)
  • Table 25. Brazil Synthetic Biology Platforms, by End User USD Million (2014-2019)
  • Table 26. Argentina Synthetic Biology Platforms, by Type USD Million (2014-2019)
  • Table 27. Argentina Synthetic Biology Platforms, by Application USD Million (2014-2019)
  • Table 28. Argentina Synthetic Biology Platforms, by End User USD Million (2014-2019)
  • Table 29. Rest of South America Synthetic Biology Platforms, by Type USD Million (2014-2019)
  • Table 30. Rest of South America Synthetic Biology Platforms, by Application USD Million (2014-2019)
  • Table 31. Rest of South America Synthetic Biology Platforms, by End User USD Million (2014-2019)
  • Table 32. Asia Pacific Synthetic Biology Platforms, by Country USD Million (2014-2019)
  • Table 33. Asia Pacific Synthetic Biology Platforms, by Type USD Million (2014-2019)
  • Table 34. Asia Pacific Synthetic Biology Platforms, by Application USD Million (2014-2019)
  • Table 35. Asia Pacific Synthetic Biology Platforms, by End User USD Million (2014-2019)
  • Table 36. China Synthetic Biology Platforms, by Type USD Million (2014-2019)
  • Table 37. China Synthetic Biology Platforms, by Application USD Million (2014-2019)
  • Table 38. China Synthetic Biology Platforms, by End User USD Million (2014-2019)
  • Table 39. Japan Synthetic Biology Platforms, by Type USD Million (2014-2019)
  • Table 40. Japan Synthetic Biology Platforms, by Application USD Million (2014-2019)
  • Table 41. Japan Synthetic Biology Platforms, by End User USD Million (2014-2019)
  • Table 42. India Synthetic Biology Platforms, by Type USD Million (2014-2019)
  • Table 43. India Synthetic Biology Platforms, by Application USD Million (2014-2019)
  • Table 44. India Synthetic Biology Platforms, by End User USD Million (2014-2019)
  • Table 45. South Korea Synthetic Biology Platforms, by Type USD Million (2014-2019)
  • Table 46. South Korea Synthetic Biology Platforms, by Application USD Million (2014-2019)
  • Table 47. South Korea Synthetic Biology Platforms, by End User USD Million (2014-2019)
  • Table 48. Taiwan Synthetic Biology Platforms, by Type USD Million (2014-2019)
  • Table 49. Taiwan Synthetic Biology Platforms, by Application USD Million (2014-2019)
  • Table 50. Taiwan Synthetic Biology Platforms, by End User USD Million (2014-2019)
  • Table 51. Australia Synthetic Biology Platforms, by Type USD Million (2014-2019)
  • Table 52. Australia Synthetic Biology Platforms, by Application USD Million (2014-2019)
  • Table 53. Australia Synthetic Biology Platforms, by End User USD Million (2014-2019)
  • Table 54. Rest of Asia-Pacific Synthetic Biology Platforms, by Type USD Million (2014-2019)
  • Table 55. Rest of Asia-Pacific Synthetic Biology Platforms, by Application USD Million (2014-2019)
  • Table 56. Rest of Asia-Pacific Synthetic Biology Platforms, by End User USD Million (2014-2019)
  • Table 57. Europe Synthetic Biology Platforms, by Country USD Million (2014-2019)
  • Table 58. Europe Synthetic Biology Platforms, by Type USD Million (2014-2019)
  • Table 59. Europe Synthetic Biology Platforms, by Application USD Million (2014-2019)
  • Table 60. Europe Synthetic Biology Platforms, by End User USD Million (2014-2019)
  • Table 61. Germany Synthetic Biology Platforms, by Type USD Million (2014-2019)
  • Table 62. Germany Synthetic Biology Platforms, by Application USD Million (2014-2019)
  • Table 63. Germany Synthetic Biology Platforms, by End User USD Million (2014-2019)
  • Table 64. France Synthetic Biology Platforms, by Type USD Million (2014-2019)
  • Table 65. France Synthetic Biology Platforms, by Application USD Million (2014-2019)
  • Table 66. France Synthetic Biology Platforms, by End User USD Million (2014-2019)
  • Table 67. Italy Synthetic Biology Platforms, by Type USD Million (2014-2019)
  • Table 68. Italy Synthetic Biology Platforms, by Application USD Million (2014-2019)
  • Table 69. Italy Synthetic Biology Platforms, by End User USD Million (2014-2019)
  • Table 70. United Kingdom Synthetic Biology Platforms, by Type USD Million (2014-2019)
  • Table 71. United Kingdom Synthetic Biology Platforms, by Application USD Million (2014-2019)
  • Table 72. United Kingdom Synthetic Biology Platforms, by End User USD Million (2014-2019)
  • Table 73. Netherlands Synthetic Biology Platforms, by Type USD Million (2014-2019)
  • Table 74. Netherlands Synthetic Biology Platforms, by Application USD Million (2014-2019)
  • Table 75. Netherlands Synthetic Biology Platforms, by End User USD Million (2014-2019)
  • Table 76. Rest of Europe Synthetic Biology Platforms, by Type USD Million (2014-2019)
  • Table 77. Rest of Europe Synthetic Biology Platforms, by Application USD Million (2014-2019)
  • Table 78. Rest of Europe Synthetic Biology Platforms, by End User USD Million (2014-2019)
  • Table 79. MEA Synthetic Biology Platforms, by Country USD Million (2014-2019)
  • Table 80. MEA Synthetic Biology Platforms, by Type USD Million (2014-2019)
  • Table 81. MEA Synthetic Biology Platforms, by Application USD Million (2014-2019)
  • Table 82. MEA Synthetic Biology Platforms, by End User USD Million (2014-2019)
  • Table 83. Middle East Synthetic Biology Platforms, by Type USD Million (2014-2019)
  • Table 84. Middle East Synthetic Biology Platforms, by Application USD Million (2014-2019)
  • Table 85. Middle East Synthetic Biology Platforms, by End User USD Million (2014-2019)
  • Table 86. Africa Synthetic Biology Platforms, by Type USD Million (2014-2019)
  • Table 87. Africa Synthetic Biology Platforms, by Application USD Million (2014-2019)
  • Table 88. Africa Synthetic Biology Platforms, by End User USD Million (2014-2019)
  • Table 89. North America Synthetic Biology Platforms, by Country USD Million (2014-2019)
  • Table 90. North America Synthetic Biology Platforms, by Type USD Million (2014-2019)
  • Table 91. North America Synthetic Biology Platforms, by Application USD Million (2014-2019)
  • Table 92. North America Synthetic Biology Platforms, by End User USD Million (2014-2019)
  • Table 93. United States Synthetic Biology Platforms, by Type USD Million (2014-2019)
  • Table 94. United States Synthetic Biology Platforms, by Application USD Million (2014-2019)
  • Table 95. United States Synthetic Biology Platforms, by End User USD Million (2014-2019)
  • Table 96. Canada Synthetic Biology Platforms, by Type USD Million (2014-2019)
  • Table 97. Canada Synthetic Biology Platforms, by Application USD Million (2014-2019)
  • Table 98. Canada Synthetic Biology Platforms, by End User USD Million (2014-2019)
  • Table 99. Mexico Synthetic Biology Platforms, by Type USD Million (2014-2019)
  • Table 100. Mexico Synthetic Biology Platforms, by Application USD Million (2014-2019)
  • Table 101. Mexico Synthetic Biology Platforms, by End User USD Million (2014-2019)
  • Table 102. Synthetic Biology Platforms: by Type(USD/Units)
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Synthetic Biology Platforms: by Type(USD Million)
  • Table 113. Synthetic Biology Platforms Synthetic Biological Tool [Oligonucleotides, Enzymes, Synthetic Cells] , by Region USD Million (2020-2025)
  • Table 114. Synthetic Biology Platforms Synthetic Biotechnology , by Region USD Million (2020-2025)
  • Table 115. Synthetic Biology Platforms: by Application(USD Million)
  • Table 116. Synthetic Biology Platforms Gene Synthesis , by Region USD Million (2020-2025)
  • Table 117. Synthetic Biology Platforms Genome Engineering , by Region USD Million (2020-2025)
  • Table 118. Synthetic Biology Platforms Cloning , by Region USD Million (2020-2025)
  • Table 119. Synthetic Biology Platforms Sequencing , by Region USD Million (2020-2025)
  • Table 120. Synthetic Biology Platforms Site-directed Mutagenesis , by Region USD Million (2020-2025)
  • Table 121. Synthetic Biology Platforms Measurement and Modeling , by Region USD Million (2020-2025)
  • Table 122. Synthetic Biology Platforms Microfluidics , by Region USD Million (2020-2025)
  • Table 123. Synthetic Biology Platforms Nanotechnology , by Region USD Million (2020-2025)
  • Table 124. Synthetic Biology Platforms Bioinformatics , by Region USD Million (2020-2025)
  • Table 125. Synthetic Biology Platforms: by End User(USD Million)
  • Table 126. Synthetic Biology Platforms Medical , by Region USD Million (2020-2025)
  • Table 127. Synthetic Biology Platforms Industry , by Region USD Million (2020-2025)
  • Table 128. Synthetic Biology Platforms Agriculture , by Region USD Million (2020-2025)
  • Table 129. Synthetic Biology Platforms Environmental , by Region USD Million (2020-2025)
  • Table 130. South America Synthetic Biology Platforms, by Country USD Million (2020-2025)
  • Table 131. South America Synthetic Biology Platforms, by Type USD Million (2020-2025)
  • Table 132. South America Synthetic Biology Platforms, by Application USD Million (2020-2025)
  • Table 133. South America Synthetic Biology Platforms, by End User USD Million (2020-2025)
  • Table 134. Brazil Synthetic Biology Platforms, by Type USD Million (2020-2025)
  • Table 135. Brazil Synthetic Biology Platforms, by Application USD Million (2020-2025)
  • Table 136. Brazil Synthetic Biology Platforms, by End User USD Million (2020-2025)
  • Table 137. Argentina Synthetic Biology Platforms, by Type USD Million (2020-2025)
  • Table 138. Argentina Synthetic Biology Platforms, by Application USD Million (2020-2025)
  • Table 139. Argentina Synthetic Biology Platforms, by End User USD Million (2020-2025)
  • Table 140. Rest of South America Synthetic Biology Platforms, by Type USD Million (2020-2025)
  • Table 141. Rest of South America Synthetic Biology Platforms, by Application USD Million (2020-2025)
  • Table 142. Rest of South America Synthetic Biology Platforms, by End User USD Million (2020-2025)
  • Table 143. Asia Pacific Synthetic Biology Platforms, by Country USD Million (2020-2025)
  • Table 144. Asia Pacific Synthetic Biology Platforms, by Type USD Million (2020-2025)
  • Table 145. Asia Pacific Synthetic Biology Platforms, by Application USD Million (2020-2025)
  • Table 146. Asia Pacific Synthetic Biology Platforms, by End User USD Million (2020-2025)
  • Table 147. China Synthetic Biology Platforms, by Type USD Million (2020-2025)
  • Table 148. China Synthetic Biology Platforms, by Application USD Million (2020-2025)
  • Table 149. China Synthetic Biology Platforms, by End User USD Million (2020-2025)
  • Table 150. Japan Synthetic Biology Platforms, by Type USD Million (2020-2025)
  • Table 151. Japan Synthetic Biology Platforms, by Application USD Million (2020-2025)
  • Table 152. Japan Synthetic Biology Platforms, by End User USD Million (2020-2025)
  • Table 153. India Synthetic Biology Platforms, by Type USD Million (2020-2025)
  • Table 154. India Synthetic Biology Platforms, by Application USD Million (2020-2025)
  • Table 155. India Synthetic Biology Platforms, by End User USD Million (2020-2025)
  • Table 156. South Korea Synthetic Biology Platforms, by Type USD Million (2020-2025)
  • Table 157. South Korea Synthetic Biology Platforms, by Application USD Million (2020-2025)
  • Table 158. South Korea Synthetic Biology Platforms, by End User USD Million (2020-2025)
  • Table 159. Taiwan Synthetic Biology Platforms, by Type USD Million (2020-2025)
  • Table 160. Taiwan Synthetic Biology Platforms, by Application USD Million (2020-2025)
  • Table 161. Taiwan Synthetic Biology Platforms, by End User USD Million (2020-2025)
  • Table 162. Australia Synthetic Biology Platforms, by Type USD Million (2020-2025)
  • Table 163. Australia Synthetic Biology Platforms, by Application USD Million (2020-2025)
  • Table 164. Australia Synthetic Biology Platforms, by End User USD Million (2020-2025)
  • Table 165. Rest of Asia-Pacific Synthetic Biology Platforms, by Type USD Million (2020-2025)
  • Table 166. Rest of Asia-Pacific Synthetic Biology Platforms, by Application USD Million (2020-2025)
  • Table 167. Rest of Asia-Pacific Synthetic Biology Platforms, by End User USD Million (2020-2025)
  • Table 168. Europe Synthetic Biology Platforms, by Country USD Million (2020-2025)
  • Table 169. Europe Synthetic Biology Platforms, by Type USD Million (2020-2025)
  • Table 170. Europe Synthetic Biology Platforms, by Application USD Million (2020-2025)
  • Table 171. Europe Synthetic Biology Platforms, by End User USD Million (2020-2025)
  • Table 172. Germany Synthetic Biology Platforms, by Type USD Million (2020-2025)
  • Table 173. Germany Synthetic Biology Platforms, by Application USD Million (2020-2025)
  • Table 174. Germany Synthetic Biology Platforms, by End User USD Million (2020-2025)
  • Table 175. France Synthetic Biology Platforms, by Type USD Million (2020-2025)
  • Table 176. France Synthetic Biology Platforms, by Application USD Million (2020-2025)
  • Table 177. France Synthetic Biology Platforms, by End User USD Million (2020-2025)
  • Table 178. Italy Synthetic Biology Platforms, by Type USD Million (2020-2025)
  • Table 179. Italy Synthetic Biology Platforms, by Application USD Million (2020-2025)
  • Table 180. Italy Synthetic Biology Platforms, by End User USD Million (2020-2025)
  • Table 181. United Kingdom Synthetic Biology Platforms, by Type USD Million (2020-2025)
  • Table 182. United Kingdom Synthetic Biology Platforms, by Application USD Million (2020-2025)
  • Table 183. United Kingdom Synthetic Biology Platforms, by End User USD Million (2020-2025)
  • Table 184. Netherlands Synthetic Biology Platforms, by Type USD Million (2020-2025)
  • Table 185. Netherlands Synthetic Biology Platforms, by Application USD Million (2020-2025)
  • Table 186. Netherlands Synthetic Biology Platforms, by End User USD Million (2020-2025)
  • Table 187. Rest of Europe Synthetic Biology Platforms, by Type USD Million (2020-2025)
  • Table 188. Rest of Europe Synthetic Biology Platforms, by Application USD Million (2020-2025)
  • Table 189. Rest of Europe Synthetic Biology Platforms, by End User USD Million (2020-2025)
  • Table 190. MEA Synthetic Biology Platforms, by Country USD Million (2020-2025)
  • Table 191. MEA Synthetic Biology Platforms, by Type USD Million (2020-2025)
  • Table 192. MEA Synthetic Biology Platforms, by Application USD Million (2020-2025)
  • Table 193. MEA Synthetic Biology Platforms, by End User USD Million (2020-2025)
  • Table 194. Middle East Synthetic Biology Platforms, by Type USD Million (2020-2025)
  • Table 195. Middle East Synthetic Biology Platforms, by Application USD Million (2020-2025)
  • Table 196. Middle East Synthetic Biology Platforms, by End User USD Million (2020-2025)
  • Table 197. Africa Synthetic Biology Platforms, by Type USD Million (2020-2025)
  • Table 198. Africa Synthetic Biology Platforms, by Application USD Million (2020-2025)
  • Table 199. Africa Synthetic Biology Platforms, by End User USD Million (2020-2025)
  • Table 200. North America Synthetic Biology Platforms, by Country USD Million (2020-2025)
  • Table 201. North America Synthetic Biology Platforms, by Type USD Million (2020-2025)
  • Table 202. North America Synthetic Biology Platforms, by Application USD Million (2020-2025)
  • Table 203. North America Synthetic Biology Platforms, by End User USD Million (2020-2025)
  • Table 204. United States Synthetic Biology Platforms, by Type USD Million (2020-2025)
  • Table 205. United States Synthetic Biology Platforms, by Application USD Million (2020-2025)
  • Table 206. United States Synthetic Biology Platforms, by End User USD Million (2020-2025)
  • Table 207. Canada Synthetic Biology Platforms, by Type USD Million (2020-2025)
  • Table 208. Canada Synthetic Biology Platforms, by Application USD Million (2020-2025)
  • Table 209. Canada Synthetic Biology Platforms, by End User USD Million (2020-2025)
  • Table 210. Mexico Synthetic Biology Platforms, by Type USD Million (2020-2025)
  • Table 211. Mexico Synthetic Biology Platforms, by Application USD Million (2020-2025)
  • Table 212. Mexico Synthetic Biology Platforms, by End User USD Million (2020-2025)
  • Table 213. Synthetic Biology Platforms: by Type(USD/Units)
  • Table 214. Research Programs/Design for This Report
  • Table 215. Key Data Information from Secondary Sources
  • Table 216. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Synthetic Biology Platforms: by Type USD Million (2014-2019)
  • Figure 5. Global Synthetic Biology Platforms: by Application USD Million (2014-2019)
  • Figure 6. Global Synthetic Biology Platforms: by End User USD Million (2014-2019)
  • Figure 7. South America Synthetic Biology Platforms Share (%), by Country
  • Figure 8. Asia Pacific Synthetic Biology Platforms Share (%), by Country
  • Figure 9. Europe Synthetic Biology Platforms Share (%), by Country
  • Figure 10. MEA Synthetic Biology Platforms Share (%), by Country
  • Figure 11. North America Synthetic Biology Platforms Share (%), by Country
  • Figure 12. Global Synthetic Biology Platforms: by Type USD/Units (2014-2019)
  • Figure 13. Global Synthetic Biology Platforms share by Players 2019 (%)
  • Figure 14. Global Synthetic Biology Platforms share by Players (Top 3) 2019(%)
  • Figure 15. Global Synthetic Biology Platforms share by Players (Top 5) 2019(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Novozymes (Denmark) Revenue, Net Income and Gross profit
  • Figure 18. Novozymes (Denmark) Revenue: by Geography 2019
  • Figure 19. Merck (United States) Revenue, Net Income and Gross profit
  • Figure 20. Merck (United States) Revenue: by Geography 2019
  • Figure 21. Intrexon (United States) Revenue, Net Income and Gross profit
  • Figure 22. Intrexon (United States) Revenue: by Geography 2019
  • Figure 23. Amyris (United States) Revenue, Net Income and Gross profit
  • Figure 24. Amyris (United States) Revenue: by Geography 2019
  • Figure 25. GenScrip (United States) Revenue, Net Income and Gross profit
  • Figure 26. GenScrip (United States) Revenue: by Geography 2019
  • Figure 27. Integrated DNA Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 28. Integrated DNA Technologies (United States) Revenue: by Geography 2019
  • Figure 29. Synthetic Genomics (United States) Revenue, Net Income and Gross profit
  • Figure 30. Synthetic Genomics (United States) Revenue: by Geography 2019
  • Figure 31. DSM (Netherlands) Revenue, Net Income and Gross profit
  • Figure 32. DSM (Netherlands) Revenue: by Geography 2019
  • Figure 33. Locus Biosciences (United States) Revenue, Net Income and Gross profit
  • Figure 34. Locus Biosciences (United States) Revenue: by Geography 2019
  • Figure 35. Global Synthetic Biology Platforms: by Type USD Million (2020-2025)
  • Figure 36. Global Synthetic Biology Platforms: by Application USD Million (2020-2025)
  • Figure 37. Global Synthetic Biology Platforms: by End User USD Million (2020-2025)
  • Figure 38. South America Synthetic Biology Platforms Share (%), by Country
  • Figure 39. Asia Pacific Synthetic Biology Platforms Share (%), by Country
  • Figure 40. Europe Synthetic Biology Platforms Share (%), by Country
  • Figure 41. MEA Synthetic Biology Platforms Share (%), by Country
  • Figure 42. North America Synthetic Biology Platforms Share (%), by Country
  • Figure 43. Global Synthetic Biology Platforms: by Type USD/Units (2020-2025)
Some of the key companies/manufacturers profiled in the report
  • Novozymes (Denmark)
  • Merck (United States)
  • Intrexon (United States)
  • Amyris (United States)
  • GenScrip (United States)
  • Integrated DNA Technologies (United States)
  • Synthetic Genomics (United States)
  • DSM (Netherlands)
  • Locus Biosciences (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation